|
The Daiichi Sankyo Group is primarily engaged in the manufacture and sale of pharmaceuticals. In the domestic segment, the Daiichi Sankyo Group is engaged in the research, development, manufacture and sale of pharmaceuticals. In addition, through its consolidated subsidiaries, the company is involved in a wide range of business activities, including R&D, manufacturing, and sales of pharmaceuticals; R&D, manufacturing, and sales of over-the-counter (OTC) drugs; R&D, manufacturing, and sales of vaccines; supply of products for the company; provision of administrative services, such as human resources and accounting; real estate leasing and insurance agency services. In the U.S., the company engages in research and development and sales of pharmaceuticals, supplies products, and consigns research and development work through its holding company and consolidated subsidiaries. |